Evaluate the Neurological Effects of EryDex on Subjects With A-T
Clinical trial NCT06193200 · COMPLETED
Trial details
- NCT number
- NCT06193200
- Sponsor
- Quince Therapeutics S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2025-12-17
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.